Back to Journals » Cancer Management and Research » Volume 12
Original Research
ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,084 | Dovepress* | 5,489+ | 951 | 6,440 | |
PubMed Central* | 595 | 178 | 773 | ||
Totals | 6,084 | 1,129 | 7,213 | ||
*Since 14 January 2020 |
View citations on PubMed Central and Google Scholar